212 related articles for article (PubMed ID: 18790802)
41. PICH promotes sister chromatid disjunction and co-operates with topoisomerase II in mitosis.
Nielsen CF; Huttner D; Bizard AH; Hirano S; Li TN; Palmai-Pallag T; Bjerregaard VA; Liu Y; Nigg EA; Wang LH; Hickson ID
Nat Commun; 2015 Dec; 6():8962. PubMed ID: 26643143
[TBL] [Abstract][Full Text] [Related]
42. Chk1 phosphorylation of Metnase enhances DNA repair but inhibits replication fork restart.
Hromas R; Williamson EA; Fnu S; Lee YJ; Park SJ; Beck BD; You JS; Leitao A; Nickoloff JA; Lee SH
Oncogene; 2012 Sep; 31(38):4245-54. PubMed ID: 22231448
[TBL] [Abstract][Full Text] [Related]
43. Leishmania actin binds and nicks kDNA as well as inhibits decatenation activity of type II topoisomerase.
Kapoor P; Kumar A; Naik R; Ganguli M; Siddiqi MI; Sahasrabuddhe AA; Gupta CM
Nucleic Acids Res; 2010 Jun; 38(10):3308-17. PubMed ID: 20147461
[TBL] [Abstract][Full Text] [Related]
44. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.
Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB
Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786
[TBL] [Abstract][Full Text] [Related]
45. MCPH1 Lack of Function Enhances Mitotic Cell Sensitivity Caused by Catalytic Inhibitors of Topo II.
Arroyo M; Sánchez A; Cañuelo A; Heredia-Molina RF; Martínez-Molina E; Clarke DJ; Marchal JA
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32276518
[TBL] [Abstract][Full Text] [Related]
46. Topoisomerase IIalpha binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy.
Wang Y; Coffey RJ; Osheroff N; Neufeld KL
PLoS One; 2010 Apr; 5(4):e9994. PubMed ID: 20368985
[TBL] [Abstract][Full Text] [Related]
47. DNA topoisomerase IIalpha interacts with CAD nuclease and is involved in chromatin condensation during apoptotic execution.
Durrieu F; Samejima K; Fortune JM; Kandels-Lewis S; Osheroff N; Earnshaw WC
Curr Biol; 2000 Jul 27-Aug 10; 10(15):923-6. PubMed ID: 10959840
[TBL] [Abstract][Full Text] [Related]
48. Nuclear interactions of topoisomerase II alpha and beta with phospholipid scramblase 1.
Wyles JP; Wu Z; Mirski SE; Cole SP
Nucleic Acids Res; 2007; 35(12):4076-85. PubMed ID: 17567603
[TBL] [Abstract][Full Text] [Related]
49. Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.
Bower JJ; Karaca GF; Zhou Y; Simpson DA; Cordeiro-Stone M; Kaufmann WK
Oncogene; 2010 Aug; 29(34):4787-99. PubMed ID: 20562910
[TBL] [Abstract][Full Text] [Related]
50. The dynamics of DNA topoisomerase IIalpha in living cells.
Daum JR; Mo YY; Gorbsky GJ
Methods Mol Biol; 2009; 582():233-44. PubMed ID: 19763954
[TBL] [Abstract][Full Text] [Related]
51. Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIalpha and beta in various human cancer cell lines.
Hochhauser D; Valkov NI; Gump JL; Wei I; O'Hare C; Hartley J; Fan J; Bertino JR; Banerjee D; Sullivan DM
J Cell Biochem; 1999 Nov; 75(2):245-57. PubMed ID: 10502297
[TBL] [Abstract][Full Text] [Related]
52. Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIalpha.
Akimitsu N; Adachi N; Hirai H; Hossain MS; Hamamoto H; Kobayashi M; Aratani Y; Koyama H; Sekimizu K
Genes Cells; 2003 Apr; 8(4):393-402. PubMed ID: 12653966
[TBL] [Abstract][Full Text] [Related]
53. Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells.
Christensen MO; Larsen MK; Barthelmes HU; Hock R; Andersen CL; Kjeldsen E; Knudsen BR; Westergaard O; Boege F; Mielke C
J Cell Biol; 2002 Apr; 157(1):31-44. PubMed ID: 11927602
[TBL] [Abstract][Full Text] [Related]
54. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.
Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J
Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042
[TBL] [Abstract][Full Text] [Related]
55. Induction of apoptosis by depletion of DNA topoisomerase IIalpha in mammalian cells.
Akimitsu N; Kamura K; Toné S; Sakaguchi A; Kikuchi A; Hamamoto H; Sekimizu K
Biochem Biophys Res Commun; 2003 Jul; 307(2):301-7. PubMed ID: 12859955
[TBL] [Abstract][Full Text] [Related]
56. Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells.
Kim HD; Tomida A; Ogiso Y; Tsuruo T
J Cell Physiol; 1999 Jul; 180(1):97-104. PubMed ID: 10362022
[TBL] [Abstract][Full Text] [Related]
57. Regulation of the catalytic function of topoisomerase II alpha through association with RNA.
Park SW; Parrott AM; Fritz DT; Park Y; Mathews MB; Lee CG
Nucleic Acids Res; 2008 Nov; 36(19):6080-90. PubMed ID: 18820297
[TBL] [Abstract][Full Text] [Related]
58. Effects of thiols on topoisomerase-II alpha activity and cell cycle progression.
Grdina DJ; Murley JS; Roberts JC
Cell Prolif; 1998; 31(5-6):217-29. PubMed ID: 9925989
[TBL] [Abstract][Full Text] [Related]
59. Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients.
Ferrandina G; Petrillo M; Carbone A; Zannoni G; Martinelli E; Prisco M; Pignata S; Breda E; Savarese A; Scambia G
Br J Cancer; 2008 Jun; 98(12):1910-5. PubMed ID: 18506140
[TBL] [Abstract][Full Text] [Related]
60. Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.
Kucukgoz Gulec U; Gumurdulu D; Guzel AB; Paydas S; Seydaoglu G; Acikalin A; Khatib G; Zeren H; Vardar MA; Altintas A
Arch Gynecol Obstet; 2014 Feb; 289(2):393-8. PubMed ID: 23974278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
